youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.57
arrow_upward
+0.78%(+0.020) 1D
$2.57
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
5 Best Dow Stocks to Buy for 2027
BigGo Finance
·
3 hours ago
Tech Valuations Fall Below Broader Market for First Time in Nine Years; S&P 500 Tech Sector Forward P/E Drops to 17x
Traders Union
·
9 hours ago
Hedge fund performance lags S&P 500 at end of October, Peter Berezin notes
TradingView
·
22 hours ago
H&S in a Falling Channel, Short Toward 7,000 for CAPITALCOM:SPX500 by Audacity618
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com